Analysts Offer Insights on Healthcare Companies: Halyard Health (NYSE: HYH), Exelixis (NASDAQ: EXEL) and Hologic (NASDAQ: HOLX)


Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Halyard Health (NYSE: HYH), Exelixis (NASDAQ: EXEL) and Hologic (NASDAQ: HOLX).

Halyard Health (NYSE: HYH)

KeyBanc analyst Matthew Mishan maintained a Buy rating on Halyard Health (NYSE: HYH) today and set a price target of $62. The company’s shares closed yesterday at $51.88, close to its 52-week high of $54.09.

According to TipRanks.com, Mishan is a 4-star analyst with an average return of 20.5% and a 91.7% success rate. Mishan covers the Healthcare sector, focusing on stocks such as Invacare Corp, Steris Corp, and Catalent.

Halyard Health has an analyst consensus of Moderate Buy, with a price target consensus of $62.

See today’s analyst top recommended stocks >>

Exelixis (NASDAQ: EXEL)

In a report released today, Stephen Willey from Stifel Nicolaus maintained a Hold rating on Exelixis (NASDAQ: EXEL), with a price target of $29. The company’s shares closed yesterday at $20.62.

According to TipRanks.com, Willey is a 5-star analyst with an average return of 22.2% and a 50.7% success rate. Willey covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals Inc, Alexion Pharmaceuticals, and Akcea Therapeutics Inc.

Exelixis has an analyst consensus of Strong Buy, with a price target consensus of $34.50.

Hologic (NASDAQ: HOLX)

In a report released today, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Hologic (NASDAQ: HOLX), with a price target of $40. The company’s shares closed yesterday at $39.64.

According to TipRanks.com, Block is a 5-star analyst with an average return of 20.6% and a 70.8% success rate. Block covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA Inc, Align Tech, and Aratana.

Currently, the analyst consensus on Hologic is Moderate Buy and the average price target is $44.63, representing a 12.6% upside.

In a report released today, Canaccord Genuity also downgraded the stock to Hold.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts